185 related articles for article (PubMed ID: 22649120)
1. DigiFab interacts with endogenous cardiotonic steroids and reverses preeclampsia-induced Na/K-ATPase inhibition.
Ishkaraeva-Yakovleva VV; Fedorova OV; Solodovnikova NG; Frolova EV; Bzhelyansky AM; Emelyanov IV; Adair CD; Zazerskaya IE; Bagrov AY
Reprod Sci; 2012 Dec; 19(12):1260-7. PubMed ID: 22649120
[TBL] [Abstract][Full Text] [Related]
2. Magnesium sulfate potentiates effect of DigiFab on marinobufagenin-induced Na/K-ATPase inhibition.
Zazerskaya IE; Ishkaraeva VV; Frolova EV; Solodovnikova NG; Grigorova YN; David Adair C; Fedorova OV; Bagrov AY
Am J Hypertens; 2013 Nov; 26(11):1269-72. PubMed ID: 23878005
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.
Fedorova OV; Simbirtsev AS; Kolodkin NI; Kotov AY; Agalakova NI; Kashkin VA; Tapilskaya NI; Bzhelyansky A; Reznik VA; Frolova EV; Nikitina ER; Budny GV; Longo DL; Lakatta EG; Bagrov AY
J Hypertens; 2008 Dec; 26(12):2414-25. PubMed ID: 19008721
[TBL] [Abstract][Full Text] [Related]
4. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia.
Averina IV; Tapilskaya NI; Reznik VA; Frolova EV; Fedorova OV; Lakatta EG; Bagrov AY
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):19-23. PubMed ID: 17535731
[TBL] [Abstract][Full Text] [Related]
5. Interaction of Digibind with endogenous cardiotonic steroids from preeclamptic placentae.
Fedorova OV; Tapilskaya NI; Bzhelyansky AM; Frolova EV; Nikitina ER; Reznik VA; Kashkin VA; Bagrov AY
J Hypertens; 2010 Feb; 28(2):361-6. PubMed ID: 19927009
[TBL] [Abstract][Full Text] [Related]
6. Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia.
Fedorova OV; Ishkaraeva VV; Grigorova YN; Reznik VA; Kolodkin NI; Zazerskaya IE; Zernetkina V; Agalakova NI; Tapilskaya NI; Adair CD; Lakatta EG; Bagrov AY
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30104471
[TBL] [Abstract][Full Text] [Related]
7. Endogenous cardiotonic steroids in chronic renal failure.
Kolmakova EV; Haller ST; Kennedy DJ; Isachkina AN; Budny GV; Frolova EV; Piecha G; Nikitina ER; Malhotra D; Fedorova OV; Shapiro JI; Bagrov AY
Nephrol Dial Transplant; 2011 Sep; 26(9):2912-9. PubMed ID: 21292813
[TBL] [Abstract][Full Text] [Related]
8. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
[TBL] [Abstract][Full Text] [Related]
9. Passive immunization against marinobufagenin attenuates renal fibrosis and improves renal function in experimental renal disease.
Haller ST; Drummond CA; Yan Y; Liu J; Tian J; Malhotra D; Shapiro JI
Am J Hypertens; 2014 Apr; 27(4):603-9. PubMed ID: 24014658
[TBL] [Abstract][Full Text] [Related]
10. Antibody against Na/K-ATPase Inhibitor Lowers Blood Pressure and Increases Vascular Fli1 in Experimental Preeclampsia.
Agalakova NI; Reznik VA; Nadei OV; Ershov IA; Rassokha OS; Vasyutina ML; Ivanov DO; Adair CD; Galagudza MM; Bagrov AY
Am J Hypertens; 2020 May; 33(6):514-519. PubMed ID: 31713584
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure.
Haller ST; Kennedy DJ; Shidyak A; Budny GV; Malhotra D; Fedorova OV; Shapiro JI; Bagrov AY
Am J Hypertens; 2012 Jun; 25(6):690-6. PubMed ID: 22378033
[TBL] [Abstract][Full Text] [Related]
12. Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake.
Fedorova OV; Kolodkin NI; Agalakova NI; Namikas AR; Bzhelyansky A; St-Louis J; Lakatta EG; Bagrov AY
J Hypertens; 2005 Apr; 23(4):835-42. PubMed ID: 15775789
[TBL] [Abstract][Full Text] [Related]
13. Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia.
Agalakova NI; Grigorova YN; Ershov IA; Reznik VA; Mikhailova EV; Nadei OV; Samuilovskaya L; Romanova LA; Adair CD; Romanova IV; Bagrov AY
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328757
[TBL] [Abstract][Full Text] [Related]
14. Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists.
Fedorova OV; Emelianov IV; Bagrov KA; Grigorova YN; Wei W; Juhasz O; Frolova EV; Marshall CA; Lakatta EG; Konradi AO; Bagrov AY
J Hypertens; 2015 Aug; 33(8):1602-10. PubMed ID: 26136067
[TBL] [Abstract][Full Text] [Related]
15. Aortic Fibrosis, Induced by High Salt Intake in the Absence of Hypertensive Response, is Reduced by a Monoclonal Antibody to Marinobufagenin.
Grigorova YN; Juhasz O; Zernetkina V; Fishbein KW; Lakatta EG; Fedorova OV; Bagrov AY
Am J Hypertens; 2016 May; 29(5):641-6. PubMed ID: 26350300
[TBL] [Abstract][Full Text] [Related]
16. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
Bagrov AY; Dmitrieva RI; Dorofeeva NA; Fedorova OV; Lopatin DA; Lakatta EG; Droy-Lefaix MT
J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
[TBL] [Abstract][Full Text] [Related]
17. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
[TBL] [Abstract][Full Text] [Related]
18. The treatment of preeclampsia in a rat model employing Digibind.
Agunanne E; Horvat D; Uddin MN; Puschett J
Am J Perinatol; 2010 Apr; 27(4):299-305. PubMed ID: 19823966
[TBL] [Abstract][Full Text] [Related]
19. Preeclampsia: Cardiotonic Steroids, Fibrosis, Fli1 and Hint to Carcinogenesis.
Agalakova NI; Kolodkin NI; Adair CD; Trashkov AP; Bagrov AY
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669287
[TBL] [Abstract][Full Text] [Related]
20. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
